SPIROSURE

Spirometrix is a California-based company, focusing on research, development, and commercialization of novel breath analysis devices for application in disease diagnosis and management. Founded in 2012, the company's mission is to provide cost-effective, non-invasive products for the management of chronic diseases such as asthma, COPD, and chronic pulmonary hypertension using a nexus of consumer technologies for preventative healthcare through our proprietary set of sensors and algorithms. The target of their first commercial product is a device that facilitates the diagnosis and management of airway inflammation (asthma) in the physician's office. The product under development is a novel diagnostic medical device to detect exhaled nitric oxide in the breath of a patient.